$93.37
Alcon is a medical instruments & supplies business based in the US. Alcon shares (ALC) are listed on the NYSE and all prices are listed in US Dollars. Alcon employs 25,000 staff and has a trailing 12-month revenue of around $9.6 billion.
Our top picks for where to buy Alcon stock
How to buy Alcon stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ALC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Alcon stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Alcon stock price (NYSE: ALC)
Use our graph to track the performance of ALC stocks over time.Alcon shares at a glance
Latest market close | $91.84 |
---|---|
52-week range | $69.21 - $92.65 |
50-day moving average | $89.49 |
200-day moving average | $80.80 |
Wall St. target price | $96.09 |
PE ratio | 42.6588 |
Dividend yield | $0.285 (0.3%) |
Earnings per share (TTM) | $2.11 |
Is it a good time to buy Alcon stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Alcon price performance over time
Historical closes compared with the close of $91.84 from 2024-07-25
1 week (2024-07-19) | 2.03% |
---|---|
1 month (2024-06-26) | 2.41% |
3 months (2024-04-26) | 16.59% |
6 months (2024-01-26) | 20.84% |
1 year (2023-07-26) | 8.21% |
---|---|
2 years (2022-07-26) | 23.18% |
3 years (2021-07-26) | 30.70% |
5 years (2019-07-26) | 55.17% |
Is Alcon stock undervalued or overvalued?
Valuing Alcon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alcon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alcon's P/E ratio
Alcon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Alcon shares trade at around 43x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Alcon's PEG ratio
Alcon's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.5934. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Alcon's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Alcon's EBITDA
Alcon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.2 billion.
The EBITDA is a measure of a Alcon's overall financial performance and is widely used to measure a its profitability.
Alcon financials
Revenue TTM | $9.6 billion |
---|---|
Operating margin TTM | 15.09% |
Gross profit TTM | $4.8 billion |
Return on assets TTM | 2.38% |
Return on equity TTM | 5.15% |
Profit margin | 10.96% |
Book value | $42.13 |
Market Capitalization | $44.7 billion |
TTM: trailing 12 months
Alcon share dividends
Dividend payout ratio: 9.39% of net profits
Recently Alcon has paid out, on average, around 9.39% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.3% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alcon shareholders could enjoy a 0.3% return on their shares, in the form of dividend payments. In Alcon's case, that would currently equate to about $0.285 per share.
While Alcon's payout ratio might seem low, this can signify that Alcon is investing more in its future growth.
Alcon's most recent dividend payout was on 15 May 2024. The latest dividend was paid out to all shareholders who bought their shares by 13 May 2024 (the "ex-dividend date").
Alcon share price volatility
Over the last 12 months, Alcon's shares have ranged in value from as little as $69.2129 up to $92.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Alcon's is 0.701. This would suggest that Alcon's shares are less volatile than average (for this exchange).
Alcon overview
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S. A.
Frequently asked questions
nullWhat percentage of Alcon is owned by insiders or institutions?
Currently 0.136% of Alcon shares are held by insiders and 72.917% by institutions. How many people work for Alcon?
Latest data suggests 25,000 work at Alcon. When does the fiscal year end for Alcon?
Alcon's fiscal year ends in December. Where is Alcon based?
Alcon's address is: Chemin de Blandonnet 8, Geneva, Switzerland, 1214 What is Alcon's ISIN number?
Alcon's international securities identification number is: CH0432492467
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question